Study to Evaluate the Efficacy and Safety of Intravenous Infusion With Nemonoxacin Malate Sodium Chloride
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to Evaluate the Efficacy, safety and pharmacokinetics of
Intravenous Nemonoxacin Compared with Intravenous Moxifloxacin in Adult Patients with
community-acquired pneumonia (CAP).
Phase:
Phase 2
Details
Lead Sponsor:
TaiGen Biotechnology Co., Ltd.
Collaborators:
QPS-Qualitix R&G Pharma Studies Co.,Ltd.
Treatments:
Fluoroquinolones Moxifloxacin Norgestimate, ethinyl estradiol drug combination